» Articles » PMID: 30700746

Safety of Resident Training in the Microsurgical Resection of Intracranial Tumors: Data from a Prospective Registry of Complications and Outcome

Overview
Journal Sci Rep
Specialty Science
Date 2019 Feb 1
PMID 30700746
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to assess the safety of microsurgical resection of intracranial tumors performed by supervised neurosurgical residents. We analyzed prospectively collected data from our institutional patient registry and dichotomized between procedures performed by supervised neurosurgery residents (defined as teaching procedures) or board-certified faculty neurosurgeons (defined as non-teaching procedures). The primary endpoint was morbidity at discharge, defined as a postoperative decrease of ≥10 points on the Karnofsky Performance Scale (KPS). Secondary endpoints included 3-month (M3) morbidity, mortality, the in-hospital complication rate, and complication type and severity. Of 1,446 consecutive procedures, 221 (15.3%) were teaching procedures. Patients in the teaching group were as likely as patients in the non-teaching group to experience discharge morbidity in both uni- (OR 0.85, 95%CI 0.60-1.22, p = 0.391) and multivariate analysis (adjusted OR 1.08, 95%CI 0.74-1.58, p = 0.680). The results were consistent at time of the M3 follow-up and in subgroup analyses. In-hospital mortality was equally low (0.24 vs. 0%, p = 0.461) and the likelihood (p = 0.499), type (p = 0.581) and severity of complications (p = 0.373) were similar. These results suggest that microsurgical resection of carefully selected intracranial tumors can be performed safely by supervised neurosurgical residents without increasing the risk of morbidity, mortality or perioperative complications. Appropriate allocation of operations according to case complexity and the resident's experience level, however, appears essential.

Citing Articles

Optimizing patient outcome in intracranial tumor surgery: a detailed prospective study of adverse events and mortality reduction strategies in neurosurgery.

Lenga P, Kleineidam H, Unterberg A, Dao Trong P Acta Neurochir (Wien). 2024; 166(1):126.

PMID: 38457057 PMC: 10923735. DOI: 10.1007/s00701-024-06008-y.


Collagen-bound fibrin sealant (TachoSil®) for dural closure in cranial surgery: single-centre comparative cohort study and systematic review of the literature.

Carretta A, Epskamp M, Ledermann L, Staartjes V, Neidert M, Regli L Neurosurg Rev. 2022; 45(6):3779-3788.

PMID: 36322203 PMC: 9663376. DOI: 10.1007/s10143-022-01886-1.


Transformation of neurosurgical training from "see one, do one, teach one" to AR/VR & simulation - A survey by the EANS Young Neurosurgeons.

Stengel F, Gandia-Gonzalez M, Aldea C, Bartek Jr J, Belo D, Ben-Shalom N Brain Spine. 2022; 2:100929.

PMID: 36248173 PMC: 9560525. DOI: 10.1016/j.bas.2022.100929.


Neurosurgery outcomes and complications in a monocentric 7-year patient registry.

Sarnthein J, Staartjes V, Regli L Brain Spine. 2022; 2:100860.

PMID: 36248111 PMC: 9560692. DOI: 10.1016/j.bas.2022.100860.


Procedures performed during neurosurgery residency in Europe.

Stienen M, Freyschlag C, Schaller K, Meling T Acta Neurochir (Wien). 2020; 162(10):2303-2311.

PMID: 32803372 PMC: 7496021. DOI: 10.1007/s00701-020-04513-4.

References
1.
Maldaner N, Sosnova M, Sarnthein J, Bozinov O, Regli L, Stienen M . Burr hole trepanation for chronic subdural hematomas: is surgical education safe?. Acta Neurochir (Wien). 2018; 160(5):901-911. DOI: 10.1007/s00701-017-3458-8. View

2.
Stienen M, Netuka D, Demetriades A, Ringel F, Gautschi O, Gempt J . Working time of neurosurgical residents in Europe--results of a multinational survey. Acta Neurochir (Wien). 2015; 158(1):17-25. DOI: 10.1007/s00701-015-2633-z. View

3.
Mut M . Surgical treatment of brain metastasis: a review. Clin Neurol Neurosurg. 2011; 114(1):1-8. DOI: 10.1016/j.clineuro.2011.10.013. View

4.
Sperduto P, Kased N, Roberge D, Xu Z, Shanley R, Luo X . Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol. 2011; 30(4):419-25. PMC: 3269967. DOI: 10.1200/JCO.2011.38.0527. View

5.
Hwang W, Marciscano A, Niemierko A, Kim D, Stemmer-Rachamimov A, Curry W . Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. Neuro Oncol. 2015; 18(6):863-72. PMC: 4864259. DOI: 10.1093/neuonc/nov285. View